Corteva, Inc. (CTVA) is now among the bigger bargains in its industry.
Within the last year the price ranged from $24.11 – 32.78 and there is a wide opportunity to get in. Its next earnings report will be released on Jan 30, 2020.

PDL BioPharma, Inc.(PDLI)

move, based on 1 analyst offering 12 month price targets for PDL bioPharma in the last 3 months. The average price target is $3.00 with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a -6.83% decrease from the last price of $3.22.

Analysts like Phil Nadeau from Cowen & Co. believe that we could see stock price minimum $3.00.

PDL BioPharma, Inc.(PDLI) Recent News Reports

On average 0.0 articles are written each week about PDLI but this week 0 articles were written and they were 60% Bullish and 40% Bearish.

PDL BioPharma, Inc. Target Levels

The market experts are predicting that PDLI is a Hold. Some other stocks to consider in this sector are:

null